Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized,Double-blind Trial Comparing the Effects of a Rivaroxaban Regimen During the First 30 Days,Versus Aspirin for the Acute Treatment of TIA or Minor Stroke

NCT01923818 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.

NCT NCT01923818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01923818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized,Double-blind Trial Comparing the Effects of a Rivaroxaban Regimen During the First 30 Days,Versus Aspirin for the Acute Treatment of TIA or Minor Stroke
Lead sponsor
Xijing Hospital
Phase
Phase 2/3
Overall status
Unknown status
Start date
September 30, 2013
Completion date
April 30, 2016
Enrollment
3,700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke, tia